ArticleBiomedicines2026

Tissue microRNA Profiling Identifies Prognostic Signatures in Prostate Cancer and Highlights CPEB3 as a Candidate Biomarker.

Jae-Heon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.